PE20181039A1 - Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituido - Google Patents
Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituidoInfo
- Publication number
- PE20181039A1 PE20181039A1 PE2018000132A PE2018000132A PE20181039A1 PE 20181039 A1 PE20181039 A1 PE 20181039A1 PE 2018000132 A PE2018000132 A PE 2018000132A PE 2018000132 A PE2018000132 A PE 2018000132A PE 20181039 A1 PE20181039 A1 PE 20181039A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- hydrogen atom
- alkyl group
- anilino
- acid derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 abstract 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- -1 2 - {[4- (trifluoromethoxy) phenyl] amino} -1 - [(1R, 5R) -3,3,5-trimethylcyclohexyl] -1H-benzimidazole -5-yl Chemical group 0.000 abstract 1
- WYDYPIFUWLGBTD-UHFFFAOYSA-N 3-(2-anilino-1-cyclohexylbenzimidazol-5-yl)propanoic acid Chemical class N(C1=CC=CC=C1)C1=NC2=C(N1C1CCCCC1)C=CC(=C2)CCC(=O)O WYDYPIFUWLGBTD-UHFFFAOYSA-N 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
LLa presente invencion se refiere a un metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil-1H-bencimidazol-5-il)propanoico sustituido de la formula general (I) donde R1 representa un atomo de hidrogeno o R1 representa un grupo que se selecciona de alquil C1-C3, alcoxi C1-C3, haloalquil C1-C3- y haloalcoxi C1-C3-; R2 representa un atomo de hidrogeno o un grupo alquilo C1- C3; R3 representa un atomo de hidrogeno o un grupo alquilo C1-C3; R4 representa un grupo C1-C3 ohexilo, el cual esta sustituido opcionalmente de manera simple o multiple por un grupo alquilo C1-C3; R5 representa un atomo de hidrogeno o un grupo alquilo C1-C6; R6 es alquilo C1-C6. Dicho metodo comprende hacer reaccionar un compuesto de formula (II) con un compuesto de formula (III) para formar un compuesto de formula (IV). Tambien se refiere a intermediarios para preparar los compuestos de formula (I). La presente invencion tambien se relaciona con una forma cristalina del acido 3-(2-{[4-(trifluorometoxi)fenil]amino}-1-[(1R,5R)-3,3,5-trimetilciclohexil]-1H-bencimidazol-5-il)propanoico y composiciones farmaceuticas que comprenden esta forma cristalina
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15178413 | 2015-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20181039A1 true PE20181039A1 (es) | 2018-07-03 |
Family
ID=53758091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018000132A PE20181039A1 (es) | 2015-07-27 | 2016-07-25 | Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituido |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10703727B2 (es) |
| EP (1) | EP3328838A1 (es) |
| JP (1) | JP6787998B2 (es) |
| KR (1) | KR20180030906A (es) |
| CN (1) | CN107848985B (es) |
| AR (1) | AR105494A1 (es) |
| AU (1) | AU2016299329B2 (es) |
| BR (1) | BR112018001535A2 (es) |
| CA (1) | CA2993480A1 (es) |
| CL (1) | CL2018000241A1 (es) |
| CO (1) | CO2018000795A2 (es) |
| HK (1) | HK1252848A1 (es) |
| IL (1) | IL256926A (es) |
| MX (1) | MX2018001204A (es) |
| PE (1) | PE20181039A1 (es) |
| RU (1) | RU2018106948A (es) |
| TW (1) | TW201718513A (es) |
| WO (1) | WO2017017046A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6688735B2 (ja) | 2014-02-11 | 2020-04-28 | バイエル・ファルマ・アクティエンゲゼルシャフト | ｍＩＤＨ１阻害剤としてのベンズイミダゾール−２−アミン |
| EP3105209B1 (en) | 2014-02-11 | 2019-08-21 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| US10137110B2 (en) | 2014-10-23 | 2018-11-27 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors |
| CN107810176B (zh) | 2015-06-08 | 2020-10-16 | 德国癌症研究公共权益基金会 | 作为mIDH1抑制剂的N-薄荷基苯并咪唑类化合物 |
| EP3319945B1 (en) | 2015-07-07 | 2021-04-28 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | 2-aryl- and 2-arylalkyl-benzimidazoles as midh1 inhibitors |
| WO2017009325A1 (en) | 2015-07-16 | 2017-01-19 | Bayer Pharma Aktiengesellschaft | 5-hydroxyalkylbenzimidazoles as midh1 inhibitors |
| EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201708193A (zh) * | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | 突變之異檸檬酸脫氫酶ｉｄｈ１ ｒ１３２ｈ之抑制劑 |
| CA3070878A1 (en) | 2017-08-01 | 2019-02-07 | Deutsches Krebsforschungszentrum | Combination of midh1 inhibitors and dna hypomethylating agents (hma) |
| KR102584855B1 (ko) * | 2018-06-26 | 2023-10-05 | 케이피씨 파마슈티컬스 인코포레이티드 | 벤즈이미다졸 유도체 및 idh1 억제제로서의 이의 용도 |
| TWI760017B (zh) * | 2019-12-23 | 2022-04-01 | 大陸商昆藥集團股份有限公司 | 一種ｉｄｈ１突變體抑制劑的鹽型、晶型及其製備方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2766550C (en) * | 2009-06-23 | 2017-04-11 | The Translational Genomics Research Intstitute | Benzamide derivatives |
| JP6688735B2 (ja) | 2014-02-11 | 2020-04-28 | バイエル・ファルマ・アクティエンゲゼルシャフト | ｍＩＤＨ１阻害剤としてのベンズイミダゾール−２−アミン |
| EP3105209B1 (en) | 2014-02-11 | 2019-08-21 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| WO2016062677A1 (en) | 2014-10-23 | 2016-04-28 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| US10137110B2 (en) | 2014-10-23 | 2018-11-27 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors |
| CN107810176B (zh) * | 2015-06-08 | 2020-10-16 | 德国癌症研究公共权益基金会 | 作为mIDH1抑制剂的N-薄荷基苯并咪唑类化合物 |
| EP3319945B1 (en) | 2015-07-07 | 2021-04-28 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | 2-aryl- and 2-arylalkyl-benzimidazoles as midh1 inhibitors |
| WO2017009325A1 (en) | 2015-07-16 | 2017-01-19 | Bayer Pharma Aktiengesellschaft | 5-hydroxyalkylbenzimidazoles as midh1 inhibitors |
| EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201708193A (zh) | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | 突變之異檸檬酸脫氫酶ｉｄｈ１ ｒ１３２ｈ之抑制劑 |
-
2016
- 2016-07-14 TW TW105122263A patent/TW201718513A/zh unknown
- 2016-07-25 HK HK18112179.8A patent/HK1252848A1/zh unknown
- 2016-07-25 CA CA2993480A patent/CA2993480A1/en not_active Abandoned
- 2016-07-25 WO PCT/EP2016/067614 patent/WO2017017046A1/en not_active Ceased
- 2016-07-25 CN CN201680043928.5A patent/CN107848985B/zh not_active Expired - Fee Related
- 2016-07-25 KR KR1020187005191A patent/KR20180030906A/ko not_active Withdrawn
- 2016-07-25 RU RU2018106948A patent/RU2018106948A/ru not_active Application Discontinuation
- 2016-07-25 US US15/748,027 patent/US10703727B2/en not_active Expired - Fee Related
- 2016-07-25 MX MX2018001204A patent/MX2018001204A/es unknown
- 2016-07-25 EP EP16741641.1A patent/EP3328838A1/en not_active Withdrawn
- 2016-07-25 JP JP2018504195A patent/JP6787998B2/ja not_active Expired - Fee Related
- 2016-07-25 BR BR112018001535A patent/BR112018001535A2/pt not_active Application Discontinuation
- 2016-07-25 AU AU2016299329A patent/AU2016299329B2/en not_active Ceased
- 2016-07-25 PE PE2018000132A patent/PE20181039A1/es unknown
- 2016-07-27 AR ARP160102275A patent/AR105494A1/es unknown
-
2018
- 2018-01-15 IL IL256926A patent/IL256926A/en unknown
- 2018-01-26 CO CONC2018/0000795A patent/CO2018000795A2/es unknown
- 2018-01-26 CL CL2018000241A patent/CL2018000241A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180222871A1 (en) | 2018-08-09 |
| MX2018001204A (es) | 2018-04-24 |
| RU2018106948A (ru) | 2019-08-27 |
| AU2016299329B2 (en) | 2020-08-13 |
| CN107848985A (zh) | 2018-03-27 |
| AU2016299329A1 (en) | 2018-02-01 |
| CN107848985B (zh) | 2021-09-03 |
| TW201718513A (zh) | 2017-06-01 |
| WO2017017046A1 (en) | 2017-02-02 |
| CO2018000795A2 (es) | 2018-05-10 |
| BR112018001535A2 (pt) | 2018-09-18 |
| AR105494A1 (es) | 2017-10-11 |
| JP2018527328A (ja) | 2018-09-20 |
| US10703727B2 (en) | 2020-07-07 |
| EP3328838A1 (en) | 2018-06-06 |
| KR20180030906A (ko) | 2018-03-26 |
| CA2993480A1 (en) | 2017-02-02 |
| HK1252848A1 (zh) | 2019-06-06 |
| IL256926A (en) | 2018-03-29 |
| CL2018000241A1 (es) | 2018-07-13 |
| JP6787998B2 (ja) | 2020-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20181039A1 (es) | Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituido | |
| AR120921A2 (es) | Herbicidas derivados de compuestos bicíclicos sustituidos con arilo | |
| AR093184A1 (es) | Compuesto de pirimidina sustituida como inhibidor de quinurenina-3-monooxigenasa y composicion farmaceutica que lo comprenden | |
| AR086474A1 (es) | Compuestos de pirazol pesticidas | |
| PE20210922A1 (es) | Pirimidinonas como inhibidores del factor xia | |
| ES2653265T3 (es) | Morfinanos sustituidos y el uso de éstos | |
| MX343611B (es) | Composicion de control de fitoenfermedades y su uso. | |
| MX377552B (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| PH12013501197B1 (en) | Indeno-fused ring compounds | |
| MX2013002461A (es) | Compuestos y composiciones novedosos para la inhibición de nampt. | |
| CO7170163A2 (es) | Composiciones fungicidas | |
| CO6680625A2 (es) | Compuesto que actuan en multiples receptores de prostaglandina que dan una respuesta antinflamatoria general | |
| ES2721662T3 (es) | Proceso para la preparación de travoprost | |
| MY172860A (en) | Dimethyl-benzoic acid compounds | |
| MX2016007567A (es) | Un nuevo compuesto de triazolo-piridina. | |
| AR083500A1 (es) | 1-(heterociclo carbonil)-pirrolidinas 2-sustituidas | |
| EA201992421A1 (ru) | Способ получения озанимода | |
| MX2018014128A (es) | 6.7.beta-epoxidos esteroideos como intermedios quimicos. | |
| WO2014188453A3 (en) | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid | |
| AR117002A2 (es) | Proceso para la preparación de inhibidores de quinasa c-fms | |
| MX2018014164A (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico. | |
| MX2021011971A (es) | Proceso para preparar cicloserinas sustituidas. | |
| CY1117087T1 (el) | Διαδικασια για την παρασκευη εστερων (5-φθορο-2-μεθυλο-3-κινολιν-2-υλμεθυλ-ινδoλ-1-υλ)- οξικου οξεος | |
| CR20160082A (es) | Nuevo derivado de triazina |